Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1994-03-14
1997-01-07
Fay, Zohreh
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
514912, A61K 31235
Patent
active
055917739
ABSTRACT:
A method of inhibiting the formation of a cataract in an eye by contacting the eye with a compound having the structure: ##STR1## is described. Also described is a method of inhibiting the progression of cataract formation in an eye. Methods comprising administering a pharmaceutical composition comprising the above compound to inhibit the formation of a cataract in the eye of a subject and to inhibit progression of cataract formation in the eye of a subject are also described. The above compound also prevents diseases resulting from oxidative stress, including diseases comprising tumor formation resulting from oxidative stress, and also inhibits the progression of diseases resulting from oxidative stress. The above compound may furthermore be used to treat an HIV infection when combined in a pharmaceutical composition with a substance which inhibits HIV replication.
REFERENCES:
patent: 5008441 (1991-04-01), Nakanishi et al.
Medline Abstract of Cancer Research, Mar. 15, 1993 Frenkel et al.
Agarawl, R., et al. Inhibition of Skin Tumor Promoter-caused Induction of Epidermal Ornithine Decarboxylase in SENCAR Mice by Polyphenolic Fraction Isolated From Green Tea and Its Individual Epicatechin Derivatives. Cancer Res. (1992) 52: 3582-3588.
Babizhayev, M. A. Accumulation of Lipid Peroxidation Products in Human Cataracts. Acta Ophthalmologica (1989) 67: 281-287.
Bhuyan, K. C., et al. Lipid Peroxidation in Cataract of the Human Life Sciences. (1986) 38: 1463-1471.
Frenkel, K. Carcinogen-Mediated Oxidant Formation and Oxidative DNA Damage. Pharmac. Ther. (1992) 53: 127-166.
Frenkel, K., et al. (abstract) Inhibition of Tumor Promoter-Mediated Oxidative Processes By Caffeic Acid Phenethyl Ester (CAPE). Proc. Amer. Assoc. Cancer Res. (1992) 33: 161.
Grunberger, D., et al. Preferential Cytotoxicity on Tumor Cells by Caffeic Acid Phenethyl Ester Isolated From Propolis. Experientia (Basel) (1988) 44: 230-232.
Huang, M. T., et al. Inhibitory Effect of Curcumin. Chlorogenic Acid. Caffeic Acid, and Ferulic Acid on Tumor Promotion in Mouse Skin by 12-0-Tetradecanoylphorbol-13-Acetate. Cancer Res. (1988) 48: 5941-5946.
Rao, C. V., et al. Effect of Caffeic Acid Esters on Carcinogen-induced Mutagenicity and Human Colon Adenocarcinoma Cell Growth. Chem.-Biol. Interactions (1992) 84: 277-290.
Smart, R. C., et al. Inhibition of 12-O-Tetradecanoylphorbol-13-Acetate Induction of Ornithine Decarboxylase Activity, DNA Synthesis, and Tumor Promotion in Mouse Skin by Ascorbic Acid and Ascorbyl Palmitte. Cancer Res. (1987) 47: 6633-6638.
Wei, H., et al. In Vivo Formation of Oxidized DNA Bases in Tumor Promoter-treated Mouse Skin. Cancer Res. (1991) 51: 4443-4449.
Wei. H., et al. Suppression of Tumor Promoter-induced Oxidative Events and DNA Damage in vivo by Sarcophytol A: A possible mechanism of antipromotion. Cancer Res. (1992) 52: 2298-2303.
Frenkel Krystyna
Grunberger Dezider
Fay Zohreh
New York University
The Trustees of Columbia University in the City of New York
White John P.
LandOfFree
Inhibition of cataract formation, diseases resulting from oxidat does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of cataract formation, diseases resulting from oxidat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of cataract formation, diseases resulting from oxidat will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1764741